NIDA Director’s Report to the - PowerPoint PPT Presentation

bernad
slide1 l.
Skip this Video
Loading SlideShow in 5 Seconds..
NIDA Director’s Report to the PowerPoint Presentation
Download Presentation
NIDA Director’s Report to the

play fullscreen
1 / 57
Download Presentation
NIDA Director’s Report to the
364 Views
Download Presentation

NIDA Director’s Report to the

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. National Advisory Council on Drug Abuse NIDA Director’s Report to the February 14, 2001

  2. Budget Update Shaping the Research Agenda Initiative Implementation Closing the “Great Divide” (a.k.a. Bridging the “Disconnect”) NIDA Director’s Report to the National Advisory Council on Drug Abuse

  3. Budget Update NIDA Director’s Report to the National Advisory Council on Drug Abuse

  4. 2000Actual 1999Actual 2001Approp. $428,490 $468,758 $535,931 $217,898 $244,902 $188,919 $686,656 $780,833 $617,409 +12.4% +13.7% +14.0% NIDA BUDGET (Thousands) NonAIDSAIDSTOTALIncrease Over Prior Year

  5. 2000Actual 1999Actual 2001Approp. 791 847 917 338 355 372 1129 1249 1337 38% 35% 34% NIDA BUDGET IMPACT Number of Research Project Grants (Excluding SBIR) Noncompeting Awards Competing AwardsTOTAL RPGs Success Rate

  6. National Institute of Biomedical Imaging and Bioengineering Establishment Act (H.R. 1795)

  7. Budget Update Shaping the Research Agenda NIDA Director’s Report to the National Advisory Council on Drug Abuse

  8. Society for Neuroscience 2000 Events: NIDA Neuroscience: Current Status And Future Directions Cellular and Molecular Mechanisms Of Synaptic Vesicle Trafficking Cross-Sensitization Between Drugs: A Behavioral and Neural Basis for “Gateway”? Minority Scholars: Research and Funding Opportunities at the National Institute on Drug Abuse

  9. DRUG ABUSE ADDICTION and Problems of Global Proportions

  10. Normal Control Methamphetamine User Pacific Regional Research Conference On Methamphetamine and Other Amphetamine-Type Stimulants

  11. Developing NIDA’s Plan for International Research

  12. We Need YOUR Help! Developing NIDA’s Plan for International Research Any Volunteers?

  13. Budget Update Shaping the Research Agenda Initiative Implementation NIDA Director’s Report to the National Advisory Council on Drug Abuse

  14. Epidemiology Treatment Neuroscience Behavioral Science Risk and Resilience Prevention AIDS and Other Medical Consequences Children and Adolescents Health Disparities Increased Dollars Are Allowing Us To Expand Efforts in Virtually All of Our Priority Areas!

  15. New RFAs “The Transition from Drug Use to Addiction: Unearthing the Switch” “Tools for Insertional Mutagenesis in the Mouse” (with numerous other NIH Institutes) “The Next Generation of Drug Abuse Prevention Research” “HIV/AIDS and Drug Use Among Adolescents” “Health and Developmental Consequences of Prenatal Exposure to Methamphetamine”

  16. New RFAs (con’t) “Research on GHB and Its Precursors” “Services Research on the National Drug Abuse Treatment Clinical Trials Network” “International Studies on Drug Abuse and HIV/AIDS” “Health Disparities: Drug Use and Its Adverse Behavioral, Social, Medical, and Mental Health Consequences” “Responding to Club Drugs and Other Emerging and Current Drug Abuse Trends” “Therapeutic Community Research”

  17. What Else Are We Doing?

  18. Prevention Epidemiology Treatment Neuroscience Behavioral Science Risk and Resilience AIDS and Other Medical Consequences Children and Adolescents Health Disparities

  19. Currently Being Updated

  20. National Prevention Research Conference August 9-10, 2001

  21. Health Disparities Epidemiology Treatment Neuroscience Behavioral Science Risk and Resilience Prevention AIDS and Other Medical Consequences Children and Adolescents

  22. AARSG NHSNDA APIRSG NARSG Combined Workgroup Meeting November 30, 2000

  23. NHSNDA on ational ispanic cience etwork rug buse First Steering Committee Meeting January 18-19, 2001

  24. National Drug Abuse Treatment Clinical Trials Network Treatment Risk and Resilience Health Disparities Epidemiology Neuroscience Behavioral Science Risk and Resilience Prevention AIDS and Other Medical Consequences Children and Adolescents Health Disparities

  25. Let’s talk about Treatment:

  26. Child Care Services Vocational Services Family Services Detoxification Housing / Transportation Services Intake Processing / Assessment Mental Health Services Behavioral Therapy and Counseling Substance Use Monitoring Treatment Plan Self-Help / Peer Support Groups Clinical and Case Management Pharmacotherapy Financial Services Medical Services Continuing Care Legal Services Educational Services AIDS / HIV Services Components of Comprehensive Drug Abuse Treatment

  27. We’re Beginning to Understand the “Black Box” of Drug Addiction Treatment

  28. Induction Behavioral Strategies Family & Friends Detoxification Early Engagement Early Recovery Motiv Patient Attributes at Intake Program Participation Behavioral Change Drug Use Drug Use Program Characteristics Counselor Attributes & Skills Crime Crime Therapeutic Relationship Psycho-Social Change Social Relations Social Relations Posttreatment Posttreatment Enhanced Counseling Social Skills Training Treatment Process and Outcomes Model Personal Health Services Supportive Networks Sufficient Retention Social Support Services Simpson, 2001 (Addiction)

  29. RESEARCH PRACTICE NIDA Treatment Initiative Blending and

  30. National Drug Abuse Treatment Clinical Trials Network The CTN Has Nearly Tripled in Size!

  31. Northwest Node Oregon Health Sciences University New England Node Yale University NYC East Side Node NY University/NY VA Med Ctr Delaware Valley Node University of PA Mid-Atlantic Node Johns Hopkins University Medical College of VA Pacific Node UCLA National Drug Abuse Treatment Clinical Trials Network

  32. Great Lakes Regional Node Wayne State University Ohio Valley Node University of Cincinnati Rocky Mountain Node University of Colorado Health Sciences Center Southeastern Node Medical University of South Carolina Florida Node University of Miami National Drug Abuse Treatment Clinical Trials Network Northwest Node Oregon Health Sciences University New England Node Yale University NYC East Side Node NY University/NY VA Med Ctr Delaware Valley Node University of PA Mid-Atlantic Node Johns Hopkins University Medical College of VA Pacific Node UCLA

  33. Pacific Northwest Node University of Washington Great Lakes Regional Node Wayne State University Long Island Regional Node NY State Psych Inst Ohio Valley Node University of Cincinnati Rocky Mountain Node University of Colorado Health Sciences Center North Carolina Node Duke University Southeastern Node Medical University of South Carolina Florida Node University of Miami National Drug Abuse Treatment Clinical Trials Network Northwest Node Oregon Health Sciences University New England Node Yale University NYC East Side Node NY University/NY VA Med Ctr Delaware Valley Node University of PA Mid-Atlantic Node Johns Hopkins University Medical College of VA Pacific Node UCLA

  34. NIDA/Managed Behavioral Healthcare Summit December 1, 2000

  35. Percentage of Male Arrestees Testing Positive for Any Drug in 1998 100 90 80 70 60 Atlanta Birmingham Chicago Cleveland Dallas Denver Detroit Ft. Lauderdale Houston Indianapolis Los Angeles Miami Minneapolis New Orleans New York City Omaha Philadelphia Phoenix Portland St. Louis Salt Lake City San Diego Seattle Washington DC 50 40 30 20 10 0 Source: 1998 Arrestee Drug Abuse Monitoring Program (ADAM) Drug Use Correlates with Crime

  36. We Need to Treat Addicted Offenders or They Will Be Back!

  37. The Good News…

  38. CRIMINAL JUSTICE HEALTH We Are Moving Toward A Better Blending of and Approaches to Addressing Drug Abuse and Addiction

  39. Percentage of Correctional Facilities Providing Substance Abuse Treatment, 1997 100 94% 90 80 70 61% 60 Percent 50 40% 40 37% 34% 30 20 10 0 Total Federal State Jail Juvenile (n=7,539) (n=129) (n=1,183) (n=3,114) (n=3,113) Source: SAMHSA, Substance Abuse Treatment in Adult and Juvenile Correctional Facilities: Findings from the Uniform Facility Data Set 1997 Survey of Correctional Facilities, 2000.

  40. The Problem is… We Don’t Know Much About the Quality of the Programs Being Used… Or the Number of Slots Being Provided

  41. The Problem is… If Treatment Access and Quality Are Inadequate It Won’t Work!

  42. We Need to Make Sure That the Blending of Health and Criminal Justice Approaches Is Not A Failed Experiment!

  43. We Need a Council Subcommittee To Define NIDA’s Research Agenda, Rapid Action Mechanisms, and Role ….Any Volunteers!

  44. Budget Update Shaping the Research Agenda Initiative Implementation Closing the “Great Divide” (a.k.a. Bridging the “Disconnect”) NIDA Director’s Report to the National Advisory Council on Drug Abuse

  45. Reality Perception Perception The “Great Divide” We Need To Close It!

  46. “Lets replace ideology with biology” Abigail Trafford 2001

  47. Science in the NEWS Turning Scientific Breakthroughs Science NEWS Into